HTG Molecular Diagnostics Announces Amendment to Senior Loan Facility
TUCSON, Ariz. , July 18, 2022 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, today announced it has entered into an amendment of its June 24, 2020 Loan and
- Category:
- Press Releases